MedTrace Logo

Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases

NCT01233544 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2016-05-12

No results posted yet for this study

Summary

This randomized clinical phase III trial is testing the efficacy of radiofrequency ablation (RFA) and stereotactic body radiotherapy (SBRT) in the treatment of colorectal carcinoma liver metastases.

Primary end point is local progression free survival.

Conditions

  • Colorectal Carcinoma
  • Liver Metastases

Interventions

PROCEDURE

SBRT or RFA

Patients are allocated to one of the two arms in a 1:1 randomization

Sponsors & Collaborators

  • Danish Center for Interventional Research in Radiation Oncology (CIRRO)

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Morten Høyer, MD PhD · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Denmark
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01233544 on ClinicalTrials.gov